Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients

European Journal of Clinical Investigation

Volumn 38, Issue 11, 2008, Pages 804-811

  Metry, G ^a   Stenvinkel, P ^a   Qureshi, A R ^a   Carrero, J J ^a   Yilmaz, M I ^a   Barany P ^a   Snaedal, S ^a   Heimburger O ^a   Lindholm, B ^a   Suliman, M E ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

Fetuin A; Haemodialysis; Inflammation; Mortality

Indexed keywords

FETUIN A; HIGH DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 54349105708     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.02032.x     Document Type: Article

References (25)

1. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001 38 : 938 42.
2. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 2003 14 : 159 68.
3. Schäfer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003 112 : 357 66.
4. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003 361 : 827 33.
5. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P et al. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int 2005 67 : 2383 92.
6. Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005 20 : 1676 85.
7. Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Boeschoten EW et al. Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007 72 : 202 7.
8. Ix JH, Shlipak MG, Sarnak MJ, Beck GJ, Greene T, Wang X et al. Fetuin-A is not associated with mortality in chronic kidney disease. Kidney Int 2007 72 : 1394 9.
9. Tsirpanlis G. Is inflammation the link between atherosclerosis and vascular calcification in chronic kidney disease? Blood Purif 2007 25 : 179 82.
10. Moe SM, Chen NX. Inflammation and vascular calcification. Blood Purif 2005 23 : 64 71.
11. Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 2002 105 : 650 5.
12. Jung HH, Kim SW, Han H. Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant 2006 21 : 1915 20.
13. Carrero JJ, Qureshi AR, Axelsson J, Avesani CM, Suliman ME, Kato S et al. Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr 2007 85 : 695 701.
14. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant 2002 17 : 1085 92.
15. Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B et al. Factors predicting malnutrition in haemodialysis patients: a cross-sectional study. Kidney Int 1998 53 : 773 82.
16. Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ. Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophage deactivating molecules. Proc Natl Acad Sci USA 1998 95 : 14429 34.
17. Wang H, Zhang M, Soda K, Sama A, Tracey KJ. Fetuin protects the fetus from TNF. Lancet 1997 350 : 861 2.
18. Demetriou M, Binkert C, Sukhu B, Tenenbaum HC, Dennis JW. Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. J Biol Chem 1996 271 : 12755 61.
19. Merx MW, Schafer C, Westenfeld R, Brandenburg V, Hidajat S, Weber C et al. Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. J Am Soc Nephrol 2005 16 : 3357 64.
20. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL et al. Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 2005 16 : 2920 30.
21. Osawa M, Yuasa I, Kitano T, Henke J, Kaneko M, Udono T et al. Haplotype analysis of the human alpha2-HS glycoprotein (fetuin) gene. Ann Hum Genet 2001 65 : 27 34.
22. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002 106 : 100 5.
23. Stompor T, Pasowicz M, Sullowicz W, Dembinska-Kiec A, Janda K, Wojcik K et al. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 2003 41 : 203 11.
24. Wang AY, Ho SS, Liu EK, Chan IH, Ho S, Sanderson JE et al. Differential associations of traditional and non-traditional risk factors with carotid intima-media thickening and plaque in peritoneal dialysis patients. Am J Nephrol 2007 27 : 458 65.
25. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 1999 34 : 618 20.